Holcombe E.  Grier , MD

President, American Society of Pediatric Hematology-Oncology

Bernstein ML, Devidas M, Lafreniere D, Souid AK, Meyers PA,Gebhardt M, Stine K, Nicholas R, Perlman EJ, Dubowy R, Wainer IW, Dickman PS,Link MP, Goorin A, Grier HE:

Intensive therapy with growth factor support for patients with ewing tumor metastatic at diagnosis: A Pediatric Oncology Group/Children`s Cancer Group phase II study (P9457).gy , 2006

Journal Clinical Oncology

Pappo AS, Devidas M, Jenkins J, Rao B, Marcua R, Thomas P, Gebhardt M, Pratt C, Grier HE.

Phase II trial of neoadjuvant vincristine, ifosfamide, and doxorubicin with granulocyte colony-stimulating factor support in children and adolescents with advanced-stage nonrhabdomyosarcomatous soft tissue

Journal Clinical Oncology

Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R, Grier

Osteosarcoma: A randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. , 2005

J Clin Oncol 23:2004-11, 2005

Research site for Holcombe Grier, MD

Sarcomas, Other Solid Tumors

• Detection and treatment of Ewing sarcoma, rhabdomyosarcoma, osteosarcoma, neuroblastoma and other pediatric soft tissue tumors (J Clin Oncol 15:583, 1997; Am J Pathol 153:1451, 1998; J Clin Oncol 16:3021, 1998; 17:3487, 1999; 18:2427, 2000; 18:2567, 2000; 19:4058, 2001; and 20:426, 2002; N Engl J Med 348:694, 2003; J Clin Oncol 22:2873, 2004; 23:4031, 2005 and 24:152, 2006)
• End-of-life care (New Engl J Med 342:326, 2000; JAMA 284:2469, 2000)
• Cancer Care - the Day 1 talk (J Clin Oncol 22: 563, 2004)

Children's Hospital Boston